Stage reports

24 findings from 27 sources across 6 stage reports

Acute Lymphoblastic Leukemia · United States ·All patients ·RUN-C8D50E0C
View Sources
24
Ready
0
Need your input
0
Decided by you
27
Sources cited
All Insights (24) Clinical (5) Treatment (3) Synthesis (4) Diagnostic (4) Logic (4) Journey (4)

Key Takeaways

Key Clinical & Treatment Insights
The discovery phase established that Acute Lymphoblastic Leukemia treatment pathways, outcomes, and regulatory positioning are highly stratified by age group, lineage subtype, Philadelphia chromosome/BCR::ABL1 status, molecular subgroup, MRD context, and relapsed/refractory status.
Ready 16 sources
Epidemiology
Acute lymphocytic leukemia in the United States has a reported incidence rate of 1.9 per 100,000 men and women per year and a death rate of 0.4 per 100,000 men and women per year. SEER reported 126,118 people living with acute lymphocytic leukemia in 2023 and a 5-year relative survival of 73.2% during 2016–2022.
Ready 9 sources

Stage outputs (6)

Disease & Diagnostic Foundation
Clinical Landscape Agent · Who gets the disease and how is it diagnosed?
70 evidence 10 sources Open
Guideline-Based Treatment Landscape & Drug/Biologic Universe
Treatment Evidence Agent · What is recommended and what is approved?
133 evidence 9 sources Open
Claims Code Universe: Diagnosis & Procedures
Diagnostic Footprint Agent · How would the clinical concepts appear in claims?
62 evidence 6 sources Open
Treatment Sequencing, Regimen Library & Code Mapping
Treatment Logic Agent · How does treatment sequence appear in real-world data?
84 evidence 9 sources Open
Patient Journey Signals: Discontinuation, Monitoring & Outcomes
Patient Journey Agent · How does a patient move through the clinical journey?
63 evidence 8 sources Open
Unmet Need Synthesis & QA Validation
Information Synthesis Agent · Where are the gaps, conflicts and limitations?
30 evidence 5 sources Open
Back to the current step All findings Document